This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Simon Gaines: Innovator in KDM5 Inhibitory Compounds
Introduction
Simon Gaines is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit KDM5 inhibitory activity. His work is crucial in the fight against various diseases, including cancer, Huntington's disease, and Alzheimer's disease.
Latest Patents
Gaines holds a patent for a compound having KDM5 inhibitory activity and its pharmaceutical use. The compound is represented by a general formula and is useful as a prophylactic and/or therapeutic agent for several serious health conditions. This innovation highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Simon Gaines is currently employed at Ono Pharmaceutical Co., Ltd., where he continues to work on groundbreaking research and development projects. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Gaines collaborates with talented individuals such as Akito Kakuuchi and Shuhei Umemura. These partnerships enhance the research efforts and contribute to the successful development of innovative pharmaceutical solutions.
Conclusion
Simon Gaines is a dedicated inventor whose work in KDM5 inhibitory compounds is paving the way for new therapeutic options. His contributions to the field of pharmaceuticals are noteworthy and have the potential to make a significant impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile